Opioid dependence and addiction during opioid treatment of chronic pain

JC Ballantyne, KS LaForge - Pain, 2007 - Elsevier
Opium, the dried juice of the seedpod of the opium poppy, has been used for the relief of
pain and suffering for several thousand years. Many opioid drugs are still derived from …

Pharmacogenetics of opioids

AA Somogyi, DT Barratt… - Clinical Pharmacology & …, 2007 - Wiley Online Library
Opioids are used for acute and chronic pain and dependency. They have a narrow
therapeutic index and large interpatient variability in response. Genetic factors regulating …

[图书][B] Genes, environment, and psychopathology: Understanding the causes of psychiatric and substance use disorders

KS Kendler, CA Prescott - 2007 - books.google.com
This groundbreaking volume synthesizes the results of the Virginia Adult Twin Study of
Psychiatric and Substance Use Disorders, which yielded longitudinal data on more than …

Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study

LA Ray, KE Hutchison - Archives of general psychiatry, 2007 - jamanetwork.com
Context Clinical trials have suggested a modest effect of naltrexone as a pharmacotherapy
for alcoholism, and a recent study has suggested that the effects may be moderated by …

The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor

T Kroslak, KS LaForge, RJ Gianotti, A Ho… - Journal of …, 2007 - Wiley Online Library
The most common single nucleotide polymorphism in the coding region of the human mu
opioid receptor gene is the A118G variant, an adenine to guanine transition at nucleotide …

Opioid Receptor Gene (OPRM1, OPRK1, and OPRD1) Variants and Response to Naltrexone Treatment for Alcohol Dependence: Results From the VA Cooperative …

J Gelernter, R Gueorguieva… - Alcoholism: Clinical …, 2007 - Wiley Online Library
Background: Pharmacotherapy of alcohol dependence (AD) is at an early stage of
development; currently available medications have limited efficacy. It would be clinically …

A Functional Polymorphism of the μ‐Opioid Receptor Gene (OPRM1) Influences Cue‐Induced Craving for Alcohol in Male Heavy Drinkers

E Van Den Wildenberg, RW Wiers… - Alcoholism: Clinical …, 2007 - Wiley Online Library
Background: The μ‐opioid receptor gene (OPRM1) codes for the μ‐opioid receptor, which
binds β‐endorphin. The A118G polymorphism in this gene affects β‐endorphin binding such …

[HTML][HTML] Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference

AC Hansson, FJ Bermúdez-Silva, H Malinen… - …, 2007 - nature.com
Endocannabinoid signaling has recently been implicated in ethanol-seeking behavior. We
analyzed the expression of endocannabinoid-related genes in key brain regions of reward …

Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking

S Krishnan-Sarin, JH Krystal, J Shi, B Pittman… - Biological …, 2007 - Elsevier
BACKGROUND: The purpose of this study was to examine the interactive effects of family
history of alcoholism (FH+, FH−) and naltrexone dose (0, 50, 100 mg/day) on alcohol …

[HTML][HTML] Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls

JM Mitchell, VC Tavares, HL Fields… - …, 2007 - nature.com
The opioid receptor antagonist naltrexone (NTX) is one of few approved treatments for
alcoholism, yet the mechanism by which it reduces drinking remains unclear. In rats, NTX …